prednisone has been researched along with Airflow Obstruction, Chronic in 89 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Possible predisposing factors included treatment with prednisone pulse therapy for obstructive pulmonary disease and prior polymyalgia rheumatica." | 7.73 | [Spontaneous bilateral rupture of the Achilles tendon in an elderly woman undergoing prednisone pulse therapy with a history of polymyalgia rheumatica]. ( de Wolf, MM; Frijns, CJ; van der Krans, A, 2006) |
| "Systemic inflammation is present in chronic obstructive pulmonary disease (COPD), which has been linked to cardiovascular morbidity and mortality." | 6.71 | Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. ( Lacy, P; Man, SF; Sin, DD; York, E, 2004) |
| "Rhinocerebral mucormycosis is a rapidly progressive and often fatal infection frequently seen in patients with uncontrolled diabetes mellitus and hematologic malignancies." | 5.34 | Rhinocerebral mucormycosis acquired after a short course of prednisone therapy. ( Ferguson, AD, 2007) |
| "We present a patient with prednisone-induced spinal epidural lipomatosis (SEL) and relatively acute neurologic deterioration followed by rapid recovery after surgical decompression." | 4.91 | Severity of presentation is associated with time to recovery in spinal epidural lipomatosis. ( D'Amico, R; Ellis, JA; Kennedy, BC; Mandigo, CE; Praver, M, 2015) |
| "A 66-year-old woman developed severe hyponatremia after receiving moxifloxacin for five days for treatment of COPD exacerbation." | 3.78 | Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin. ( Eraly, SA; Yam, FK, 2012) |
| " In Spain, however, a HIV-negative man with a history of chronic obstructive pulmonary disease and prednisone treatment was recently hospitalized because of hypotension and asthenia." | 3.73 | Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate. ( Garcia-Cordoba, F; Gonzalez Diaz, G; Ortuño, FJ; Segovia, M, 2005) |
| " Possible predisposing factors included treatment with prednisone pulse therapy for obstructive pulmonary disease and prior polymyalgia rheumatica." | 3.73 | [Spontaneous bilateral rupture of the Achilles tendon in an elderly woman undergoing prednisone pulse therapy with a history of polymyalgia rheumatica]. ( de Wolf, MM; Frijns, CJ; van der Krans, A, 2006) |
| "Chronic obstructive pulmonary disease (COPD) is a major public health issue affecting approximately 4% to 7% of the Swiss population." | 2.90 | Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial). ( Abig, K; Bachler, H; Boesing, M; Cattaneo, M; Dieterle, T; Essig, S; Leuppi, JD; Markun, S; Merlo, C; Rutishauser, J; Schuurmans, MM; Senn, O; Ullmer, E; Urwyler, P; Zeller, A, 2019) |
| "The prednisone cohort was registered at clinicalTrials." | 2.90 | Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial. ( Chen, V; FitzGerald, JM; Hollander, Z; McManus, BM; Ng, RT; Obeidat, M; Sin, DD; Takiguchi, H, 2019) |
| "Treatment with dapagliflozin was safe and there was no difference in risk of hypoglycaemia compared with placebo." | 2.87 | Dapagliflozin for prednisone-induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease. ( Brandjes, DPM; Gerards, MC; Gerdes, VEA; Hageman, IMG; Hoekstra, JBL; Kross, M; Patberg, KW; Potter van Loon, BJ; Snijders, D; Venema, GE; Vriesendorp, TM, 2018) |
| "Of 314 patients with AECOPD randomised to 5 or 14 days of prednisone treatment, 311 were included in the analysis." | 2.84 | Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial. ( Engel, B; Leuppi, JD; Rutishauser, J; Schindler, C, 2017) |
| "30 patients presenting to ED with AECOPD were included." | 2.80 | Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study. ( Armstrong, P; Clayton-Smith, B; Hardy, M; Marchant, G; Marsh, E; Mukerji, S; Shahpuri, B; Smith, N, 2015) |
| "Prednisone was stopped abruptly, irrespective of the test results." | 2.80 | Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. ( Bingisser, R; Bodmer, M; Briel, M; Drescher, T; Duerring, U; Henzen, C; Leibbrandt, Y; Leuppi, JD; Maier, S; Miedinger, D; Mueller, B; Rutishauser, J; Scherr, A; Schindler, C; Schuetz, P; Stoeckli, R; Tamm, M; Viatte, S; von Garnier, C, 2015) |
| "Patients hospitalized for COPD in the past year." | 2.77 | A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. ( Adams, SG; Bourbeau, J; Colling, C; Fan, VS; Fiore, L; Gaziano, JM; Huang, GD; Leatherman, S; Lew, R; Liang, MH; Mador, MJ; Mazzuca, SA; Niewoehner, DE; Panos, RJ; Rastogi, P; Robbins, R; Sarosi, G; Shannon, C; Sharafkhaneh, A; Sriram, PS; Stoller, JK; Thwin, SS; Wagner, TH, 2012) |
| "With prednisone, there was a net increase of 13 m in 6MWD (P = 0." | 2.74 | Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide. ( Condliffe, R; Cook, JM; Cowan, JO; Dummer, JF; Epton, MJ; Landhuis, CE; Smith, AD; Taylor, DR, 2009) |
| "In patients with COPD and CAP, the time courses over 7 days of PCT and CRP showed a nearly parallel decline compared to non-COPD patients with CAP." | 2.73 | Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia. ( Capelli, B; Cerutti, B; Domenighetti, G; Duchini, F; Lepori, M; Perren, A; Senn, V, 2008) |
| "Patients with severe COPD (stages III-IV, classification of the Global Initiative for Chronic Obstructive Lung Disease) and incapacitating dyspnea (scores 3-5, Medical Research Council [MRC] scale) were randomized to a control or domiciliary rehabilitation group." | 2.73 | [Benefits of a home-based pulmonary rehabilitation program for patients with severe chronic obstructive pulmonary disease]. ( Casan Clarà, P; Gáldiz, JB; Gorostiza, A; Güell Rous, R; López de Santa María, E; Regiane Resqueti, V, 2007) |
| "Participants were 159 patients with COPD randomized by general practice site into control or intervention groups." | 2.72 | Self-management plans in the primary care of patients with chronic obstructive pulmonary disease. ( Cook, JM; Dowson, CA; Epton, MJ; Frampton, CM; McCartin, FJ; McGeoch, GR; Town, GI; Willsman, KJ, 2006) |
| "Systemic inflammation is present in chronic obstructive pulmonary disease (COPD), which has been linked to cardiovascular morbidity and mortality." | 2.71 | Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. ( Lacy, P; Man, SF; Sin, DD; York, E, 2004) |
| "Of 36 moderate to severe COPD patients started on prednisone, 30 completed the study according to the protocol." | 2.71 | Time to spirometric and exercise response in 4-week oral corticosteroid trial for stable COPD patients. ( Bolliger, CT; Botha, P; Richter, DC; Schuurmans, MM; Steyn, D, 2005) |
| "Acute exacerbations of chronic obstructive pulmonary disease (COPD)--characterized by shortness of breath, increased sputum production, increased purulence, or a combination of these signs--are costly and can have major impacts on the patient's health." | 2.53 | Treating and preventing acute exacerbations of COPD. ( Aboussouan, LS; Hatipoglu, US, 2016) |
| "In patients with exacerbations of chronic obstructive pulmonary disease (COPD) requiring hospitalisation, 5 days of corticosteroid therapy appears to be as effective as 14 days of corticosteroid therapy for preventing recurrences." | 2.50 | COPD exacerbations: 5 days of corticosteroid therapy. ( , 2014) |
| "COPD is the 5th leading cause of death in the United States." | 2.44 | Steroid allergy? A case report and review of the literature. ( Danley, SG, 2007) |
| "Prednisone was the most frequently implicated corticosteroid, but cases involving ACTH, cortisone, and high-dose inhaled dexamethasone and beclomethasone were also identified." | 2.44 | Drug dependence involving prednisone: two cases and a review of the literature. ( Anfinson, TJ; Channappa, C; Vo, HT, 2008) |
| " However, the most appropriate dosage regimen remains controversial, as the corticosteroid regimens used in these trials differed greatly, and no studies have directly compared medium-, high-, and low-dose regimens." | 2.43 | Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease? ( Hemstreet, BA; Vondracek, SF, 2006) |
| "In elderly subjects with COPD, CAT were associated significantly with the risk of COPD exacerbation, with PNI also a potential predictor." | 1.91 | Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients. ( Anazawa, R; Ikari, J; Kawata, N; Sato, H; Shiko, Y; Shimada, A; Suzuki, E; Suzuki, M; Suzuki, T; Tatsumi, K; Yamamoto, M, 2023) |
| "Patients with a history of chronic obstructive pulmonary disease (COPD) or asthma undergoing surgery are at risk for developing postoperative pulmonary complications, associated with morbidity and mortality." | 1.72 | [Dutch guideline to prevent perioperative pulmonal complications: how is the adherence?] ( Bronsveld, I; Kappen, T; Marsman, M; Miggelbrink, LA; Senff, JR; van Klei, W; van Waes, JAR, 2022) |
| "A multifaceted stewardship intervention significantly reduced steroid dosing in hospitalized AECOPD patients." | 1.72 | A multifaceted stewardship intervention helps curb steroid overprescribing in hospitalized patients with acute exacerbations of COPD. ( Cole, JL; Smith, SE, 2022) |
| "Initial dosing ranged from 40 to 625 mg/day with only four responders (13%) selecting 40 mg/day." | 1.56 | Provider perceptions on steroid dosing in AECOPD: Laying the groundwork for steroid stewardship. ( Cole, JL; Smith, S, 2020) |
| "Effective inpatient chronic obstructive pulmonary disease (COPD) exacerbation management is critical to appropriately manage health care resources." | 1.51 | Systemic Corticosteroid and Antibiotic Use in Hospitalized Patients With Chronic Obstructive Pulmonary Disease Exacerbation. ( Murphy, JA; Petite, SE, 2019) |
| "Our EHS-based "COPD PowerPlan" order set included admission, laboratory, pharmacy, and radiology orders for managing AECOPD." | 1.48 | The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study. ( Bhatt, SP; Davison, PN; Dransfield, MT; Gulati, S; Kalehoff, JP; Kirkpatrick, DP; Wells, JM; Wren, CS; Zouk, AN, 2018) |
| " Secondary outcome measures were corticosteroid dosage during the entire hospitalization, length of stay, hospital follow-up rates, and 30-day readmission rates." | 1.40 | Improving adherence for management of acute exacerbation of chronic obstructive pulmonary disease. ( Clark, C; Seidensticker, S; Sharma, G; Sonstein, L; Zeng, L, 2014) |
| "ABPA in COPD is uncommon, but early identification and initiation of systemic corticosteroid therapy can lead to improvement in symptoms and prognosis." | 1.39 | [Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of 3 cases]. ( Jin, JM; Li, R; Liu, XF; Liu, Y; Sun, YC, 2013) |
| "Smartphone-based collection of COPD symptom diaries enables near-complete identification of exacerbations at inception." | 1.39 | Detection of COPD Exacerbations and compliance with patient-reported daily symptom diaries using a smart phone-based information system [corrected]. ( Coyle, PV; de Verdier, MG; Higenbottam, T; Hussack, P; Jenkins, M; Johnston, NW; Lambert, K; Lewis, J; McIvor, RA; Newbold, P; Norman, GR, 2013) |
| "We analyzed COPD subjects with GOLD I-IV disease in the COPDGene® study." | 1.38 | Demographic, physiologic and radiographic characteristics of COPD patients taking chronic systemic corticosteroids. ( Criner, GJ; Kim, V; Make, BJ; Murphy, JR; Newell, J; Satti, A; Silverman, EK; Steiner, RM; Swift, I; Wilson, C, 2012) |
| "Severe COPD is associated with increased levels of HDL-C, which is partially attributable to oral steroid use." | 1.37 | Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol. ( DeFilippis, A; Eberlein, M; Girgis, RE; Iacono, A; Jones, S; Reed, RM, 2011) |
| "A common extrapulmonary effect to chronic obstructive pulmonary disease (COPD) is osteoporosis." | 1.36 | Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease - a population-based database study. ( Brixen, K; Hallas, J; Madsen, H, 2010) |
| "Rhinocerebral mucormycosis is a rapidly progressive and often fatal infection frequently seen in patients with uncontrolled diabetes mellitus and hematologic malignancies." | 1.34 | Rhinocerebral mucormycosis acquired after a short course of prednisone therapy. ( Ferguson, AD, 2007) |
| "Acute exacerbation of COPD (AE-COPD) is a major problem influencing patient outcome, increasing both economic burden and mortality." | 1.33 | [Cost analysis for inpatient therapy for patients with acute exacerbations of chronic obstructive pulmonary disease]. ( Kida, K; Motegi, T; Yamada, K, 2006) |
| "Treatment with prednisone did not influence the levels of IL-8." | 1.32 | Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids. ( Barczyk, A; Pierzchala, W; Sozañska, E; Trzaska, M, 2004) |
| "A 69-year-old man with chronic obstructive pulmonary disease (COPD) presented with an exacerbation of cough and breathlessness, as well as a 5 day history of sudden-onset bilateral calf tenderness." | 1.31 | Spontaneous bilateral rupture of the Achilles tendon in a patient with chronic obstructive pulmonary disease. ( Horsley, M; Khurana, R; Mahoney, J; Torzillo, PJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 35 (39.33) | 29.6817 |
| 2010's | 44 (49.44) | 24.3611 |
| 2020's | 10 (11.24) | 2.80 |
| Authors | Studies |
|---|---|
| Kaviani, A | 1 |
| Khansari Nejad, N | 1 |
| Akour, A | 1 |
| AlMuhaissen, SA | 1 |
| Nusair, MB | 1 |
| Al-Tammemi, AB | 1 |
| Mahmoud, NN | 1 |
| Jalouqa, S | 1 |
| Alrawashdeh, MN | 1 |
| Shanahan, JP | 1 |
| Moore, CM | 1 |
| Kampf, JW | 1 |
| Szymczak, NK | 1 |
| Guo, J | 1 |
| Wang, H | 1 |
| Luo, Y | 1 |
| An, H | 1 |
| Zhang, Z | 2 |
| Liu, G | 1 |
| Li, J | 1 |
| Metcalfe, GD | 1 |
| Smith, TW | 1 |
| Hippler, M | 1 |
| Ayala Izurieta, JE | 1 |
| Márquez, CO | 1 |
| García, VJ | 1 |
| Jara Santillán, CA | 1 |
| Sisti, JM | 1 |
| Pasqualotto, N | 1 |
| Van Wittenberghe, S | 1 |
| Delegido, J | 1 |
| Kubo, Y | 1 |
| Kitagawa, Y | 1 |
| Miyazaki, T | 1 |
| Sohda, M | 1 |
| Yamaji, T | 1 |
| Sakai, M | 1 |
| Saeki, H | 1 |
| Nemoto, K | 1 |
| Oyama, T | 2 |
| Muto, M | 1 |
| Takeuchi, H | 1 |
| Toh, Y | 1 |
| Matsubara, H | 1 |
| Mano, M | 1 |
| Kono, K | 1 |
| Kato, K | 1 |
| Yoshida, M | 1 |
| Kawakubo, H | 1 |
| Booka, E | 1 |
| Yamatsuji, T | 1 |
| Kato, H | 1 |
| Ito, Y | 1 |
| Ishikawa, H | 1 |
| Ishihara, R | 1 |
| Tsushima, T | 1 |
| Kawachi, H | 1 |
| Kojima, T | 1 |
| Kuribayashi, S | 1 |
| Makino, T | 1 |
| Matsuda, S | 1 |
| Doki, Y | 1 |
| Ma, P | 1 |
| Tang, X | 1 |
| Zhang, L | 2 |
| Wang, X | 1 |
| Wang, W | 1 |
| Zhang, X | 1 |
| Wang, S | 2 |
| Zhou, N | 1 |
| Dodd, J | 1 |
| Jordan, R | 1 |
| Makhlina, M | 1 |
| Pesco Koplowitz, L | 1 |
| Koplowitz, B | 1 |
| Barnett, K | 1 |
| Yang, WH | 1 |
| Spana, C | 1 |
| Buchanan, SW | 1 |
| Mafa-Attoye, T | 1 |
| Dunfield, K | 1 |
| Thevathasan, NV | 1 |
| Isaac, ME | 1 |
| Wu, X | 2 |
| Huang, JW | 1 |
| Su, BK | 1 |
| Yuan, L | 1 |
| Zheng, WQ | 1 |
| Zhang, H | 2 |
| Zheng, YX | 1 |
| Zhu, W | 1 |
| Chou, PT | 1 |
| Manso, AP | 1 |
| De Morais, DC | 1 |
| Yamamoto, K | 1 |
| Owen, G | 1 |
| de Carvalho, RM | 1 |
| Palma-Dibb, RG | 1 |
| Brown, JC | 1 |
| Yang, S | 1 |
| Mire, EF | 1 |
| Miele, L | 1 |
| Ochoa, A | 1 |
| Zabaleta, J | 1 |
| Katzmarzyk, PT | 1 |
| Moi, CT | 1 |
| Bhowmick, S | 1 |
| Qureshi, M | 1 |
| Wang, K | 1 |
| Feng, B | 1 |
| Yang, Y | 1 |
| Chen, Y | 1 |
| Wang, Y | 2 |
| Yang, L | 1 |
| Jiang, K | 1 |
| James, TD | 1 |
| Chaturvedi, V | 1 |
| Postiglione, WM | 1 |
| Chakraborty, RD | 1 |
| Yu, B | 1 |
| Tabiś, W | 1 |
| Hameed, S | 1 |
| Biniskos, N | 1 |
| Jacobson, A | 1 |
| Zhou, H | 1 |
| Greven, M | 1 |
| Ferry, VE | 1 |
| Leighton, C | 1 |
| Wu, F | 1 |
| Lei, H | 1 |
| Chen, G | 1 |
| Chen, C | 1 |
| Song, Y | 1 |
| Cao, Z | 1 |
| Zhang, C | 2 |
| Zhou, J | 1 |
| Lu, Y | 1 |
| Pappone, C | 1 |
| Santinelli, V | 1 |
| Mecarocci, V | 1 |
| Tondi, L | 1 |
| Ciconte, G | 1 |
| Manguso, F | 1 |
| Sturla, F | 1 |
| Vicedomini, G | 1 |
| Micaglio, E | 1 |
| Anastasia, L | 1 |
| Pica, S | 1 |
| Camporeale, A | 1 |
| Lombardi, M | 1 |
| Shieh, PB | 1 |
| Elfring, G | 1 |
| Trifillis, P | 1 |
| Santos, C | 1 |
| Peltz, SW | 1 |
| Parsons, JA | 1 |
| Apkon, S | 1 |
| Darras, BT | 1 |
| Campbell, C | 1 |
| McDonald, CM | 1 |
| Galaviz, KI | 1 |
| Shah, NS | 1 |
| Gutierrez, M | 1 |
| Collins, LF | 1 |
| Lahiri, CD | 1 |
| Moran, CA | 1 |
| Szabo, B | 1 |
| Sumitani, J | 1 |
| Rhodes, J | 1 |
| Marconi, VC | 1 |
| Nguyen, ML | 1 |
| Cantos, VD | 1 |
| Armstrong, WS | 1 |
| Colasanti, JA | 1 |
| Cole, JL | 2 |
| Smith, SE | 1 |
| Miggelbrink, LA | 1 |
| Marsman, M | 1 |
| Senff, JR | 1 |
| van Waes, JAR | 1 |
| Bronsveld, I | 1 |
| van Klei, W | 1 |
| Kappen, T | 1 |
| Suzuki, E | 1 |
| Kawata, N | 1 |
| Shimada, A | 1 |
| Sato, H | 1 |
| Anazawa, R | 1 |
| Suzuki, M | 1 |
| Shiko, Y | 1 |
| Yamamoto, M | 1 |
| Ikari, J | 1 |
| Tatsumi, K | 1 |
| Suzuki, T | 1 |
| Urwyler, P | 1 |
| Boesing, M | 1 |
| Abig, K | 1 |
| Cattaneo, M | 1 |
| Dieterle, T | 1 |
| Zeller, A | 1 |
| Bachler, H | 1 |
| Markun, S | 1 |
| Senn, O | 1 |
| Merlo, C | 1 |
| Essig, S | 1 |
| Ullmer, E | 1 |
| Rutishauser, J | 4 |
| Schuurmans, MM | 2 |
| Leuppi, JD | 4 |
| Smith, S | 1 |
| George, J | 1 |
| Ganoff, M | 1 |
| Lipari, M | 1 |
| Dameron, M | 1 |
| Horowitz, M | 1 |
| Gupta, N | 1 |
| Abi Hatem, N | 1 |
| Chuzi, S | 1 |
| Kuang, F | 1 |
| Khan, SS | 1 |
| Chong, WH | 1 |
| Ibrahim, A | 1 |
| Saha, BK | 1 |
| Singh, AD | 1 |
| Mian, A | 1 |
| Stoller, JK | 2 |
| McCann, J | 1 |
| Teare, K | 1 |
| Cochard, E | 1 |
| Toney, B | 1 |
| Engel, B | 1 |
| Schindler, C | 3 |
| Gerards, MC | 1 |
| Venema, GE | 1 |
| Patberg, KW | 1 |
| Kross, M | 1 |
| Potter van Loon, BJ | 1 |
| Hageman, IMG | 1 |
| Snijders, D | 2 |
| Brandjes, DPM | 1 |
| Hoekstra, JBL | 1 |
| Vriesendorp, TM | 1 |
| Gerdes, VEA | 1 |
| Gulati, S | 1 |
| Zouk, AN | 1 |
| Kalehoff, JP | 1 |
| Wren, CS | 1 |
| Davison, PN | 1 |
| Kirkpatrick, DP | 1 |
| Bhatt, SP | 1 |
| Dransfield, MT | 1 |
| Wells, JM | 1 |
| Petite, SE | 1 |
| Murphy, JA | 1 |
| Mahajan, KR | 1 |
| Tacoronte Pérez, S | 1 |
| Cerón Navarro, J | 1 |
| Pastor Colom, A | 1 |
| Morcillo Aixelá, A | 1 |
| Ricciuti, B | 1 |
| Dahlberg, SE | 1 |
| Adeni, A | 1 |
| Sholl, LM | 1 |
| Nishino, M | 1 |
| Awad, MM | 1 |
| Takiguchi, H | 1 |
| Chen, V | 1 |
| Obeidat, M | 1 |
| Hollander, Z | 1 |
| FitzGerald, JM | 2 |
| McManus, BM | 1 |
| Ng, RT | 1 |
| Sin, DD | 4 |
| Crespo-Lessmann, A | 1 |
| Torrego-Fernández, A | 1 |
| Johnston, NW | 1 |
| Lambert, K | 1 |
| Hussack, P | 1 |
| de Verdier, MG | 1 |
| Higenbottam, T | 1 |
| Lewis, J | 1 |
| Newbold, P | 1 |
| Jenkins, M | 1 |
| Norman, GR | 1 |
| Coyle, PV | 1 |
| McIvor, RA | 2 |
| Schuetz, P | 3 |
| Bingisser, R | 2 |
| Bodmer, M | 2 |
| Briel, M | 2 |
| Drescher, T | 2 |
| Duerring, U | 2 |
| Henzen, C | 2 |
| Leibbrandt, Y | 2 |
| Maier, S | 2 |
| Miedinger, D | 2 |
| Müller, B | 2 |
| Scherr, A | 2 |
| Stoeckli, R | 2 |
| Viatte, S | 2 |
| von Garnier, C | 2 |
| Tamm, M | 2 |
| Park, HY | 1 |
| Abroug, F | 1 |
| Ouanes-Besbes, L | 1 |
| Fkih-Hassen, M | 1 |
| Ouanes, I | 1 |
| Ayed, S | 1 |
| Dachraoui, F | 1 |
| Brochard, L | 1 |
| Elatrous, S | 1 |
| Schuster, S | 1 |
| Diethelm, M | 1 |
| Steurer, J | 1 |
| Neuvians, T | 1 |
| Maselli, DJ | 1 |
| Peters, JI | 1 |
| Sethi, S | 2 |
| Nag, N | 1 |
| Liu, XF | 1 |
| Sun, YC | 1 |
| Jin, JM | 1 |
| Li, R | 1 |
| Liu, Y | 1 |
| Asher, GN | 1 |
| Mounsey, A | 1 |
| Tikotekar, A | 1 |
| Jagpal, S | 1 |
| Nagella, N | 1 |
| Similowski, T | 1 |
| Suissa, S | 1 |
| Sonstein, L | 1 |
| Clark, C | 1 |
| Seidensticker, S | 1 |
| Zeng, L | 1 |
| Sharma, G | 1 |
| Mueller, B | 1 |
| Praver, M | 1 |
| Kennedy, BC | 1 |
| Ellis, JA | 1 |
| D'Amico, R | 1 |
| Mandigo, CE | 1 |
| Mukerji, S | 1 |
| Shahpuri, B | 1 |
| Clayton-Smith, B | 1 |
| Smith, N | 1 |
| Armstrong, P | 1 |
| Hardy, M | 1 |
| Marchant, G | 1 |
| Marsh, E | 1 |
| Hatipoglu, US | 1 |
| Aboussouan, LS | 1 |
| Patel, KP | 1 |
| Vaidya, A | 1 |
| Gibson, CJ | 1 |
| Henrich, TJ | 1 |
| Lyons, JL | 1 |
| Martinez, FJ | 1 |
| Rabe, KF | 1 |
| Ferguson, GT | 1 |
| Fabbri, LM | 1 |
| Rennard, S | 1 |
| Feldman, GJ | 1 |
| Spangenthal, S | 1 |
| Gottschlich, GM | 1 |
| Rodriguez-Roisin, R | 1 |
| Arora, S | 1 |
| Siler, TM | 1 |
| Siddiqui, S | 1 |
| Darken, P | 1 |
| Fischer, T | 1 |
| Maes, A | 1 |
| Golden, M | 1 |
| Orevillo, C | 1 |
| Reisner, C | 1 |
| Cerceo, E | 1 |
| Kotloff, RM | 1 |
| Hadjiliadis, D | 1 |
| Ahya, VN | 1 |
| Pochettino, A | 1 |
| Gillespie, C | 1 |
| Christie, JD | 1 |
| Dummer, JF | 1 |
| Epton, MJ | 2 |
| Cowan, JO | 1 |
| Cook, JM | 2 |
| Condliffe, R | 1 |
| Landhuis, CE | 1 |
| Smith, AD | 1 |
| Taylor, DR | 1 |
| Daniels, JM | 1 |
| de Graaff, CS | 1 |
| Vlaspolder, F | 1 |
| Jansen, HM | 1 |
| Boersma, WG | 1 |
| Marchand, E | 1 |
| Madsen, H | 1 |
| Brixen, K | 1 |
| Hallas, J | 1 |
| Bugano, DD | 1 |
| Campos, SV | 1 |
| Afonso, JE | 1 |
| Caramori, ML | 1 |
| Teixeira, RH | 1 |
| Carraro, RM | 1 |
| Strabelli, TM | 1 |
| Machado, CM | 1 |
| Samano, MN | 1 |
| Pêgo-Fernandes, P | 1 |
| Jatene, FB | 1 |
| Bischoff, EW | 1 |
| Hamd, DH | 1 |
| Sedeno, M | 1 |
| Benedetti, A | 1 |
| Schermer, TR | 1 |
| Bernard, S | 1 |
| Maltais, F | 2 |
| Bourbeau, J | 3 |
| Reed, RM | 1 |
| Iacono, A | 1 |
| DeFilippis, A | 1 |
| Eberlein, M | 1 |
| Girgis, RE | 1 |
| Jones, S | 1 |
| Yam, FK | 1 |
| Eraly, SA | 1 |
| Swift, I | 1 |
| Satti, A | 1 |
| Kim, V | 1 |
| Make, BJ | 1 |
| Newell, J | 1 |
| Steiner, RM | 1 |
| Wilson, C | 1 |
| Murphy, JR | 1 |
| Silverman, EK | 1 |
| Criner, GJ | 1 |
| Fan, VS | 1 |
| Gaziano, JM | 1 |
| Lew, R | 1 |
| Adams, SG | 1 |
| Leatherman, S | 1 |
| Thwin, SS | 1 |
| Huang, GD | 1 |
| Robbins, R | 1 |
| Sriram, PS | 1 |
| Sharafkhaneh, A | 1 |
| Mador, MJ | 1 |
| Sarosi, G | 1 |
| Panos, RJ | 1 |
| Rastogi, P | 1 |
| Wagner, TH | 1 |
| Mazzuca, SA | 1 |
| Shannon, C | 1 |
| Colling, C | 1 |
| Liang, MH | 1 |
| Fiore, L | 1 |
| Niewoehner, DE | 2 |
| Garber, K | 1 |
| Aaron, SD | 2 |
| Vandemheen, KL | 2 |
| Field, SK | 1 |
| Marciniuk, DD | 1 |
| Nair, P | 1 |
| Mallick, R | 1 |
| Hebert, P | 1 |
| Dales, R | 1 |
| Stiell, IG | 1 |
| Ahuja, J | 1 |
| Dickinson, G | 1 |
| Brison, R | 1 |
| Rowe, BH | 1 |
| Dreyer, J | 1 |
| Yetisir, E | 1 |
| Cass, D | 1 |
| Wells, G | 1 |
| Irwin, RS | 1 |
| Madison, JM | 1 |
| Motta, AC | 1 |
| Arruda, D | 1 |
| Souza, CS | 1 |
| Foss, NT | 1 |
| Busti, AJ | 1 |
| Vervan, MD | 1 |
| Brouse, SD | 1 |
| Hurst, JR | 1 |
| Donaldson, GC | 1 |
| Wedzicha, JA | 1 |
| Salloum, A | 1 |
| Elbaage, TY | 1 |
| Soubani, AO | 1 |
| Rolla, G | 1 |
| Bucca, C | 1 |
| Courtney, AU | 1 |
| McDiarmid, T | 1 |
| Mackler, L | 1 |
| Briscoe, D | 1 |
| McDiarmuid, T | 1 |
| Lacy, P | 1 |
| York, E | 1 |
| Man, SF | 1 |
| Barczyk, A | 1 |
| Sozañska, E | 1 |
| Trzaska, M | 1 |
| Pierzchala, W | 1 |
| Broseghini, C | 1 |
| Testi, R | 1 |
| Polese, G | 1 |
| Tosatto, R | 1 |
| Rossi, A | 1 |
| Garcia-Cordoba, F | 1 |
| Ortuño, FJ | 1 |
| Segovia, M | 1 |
| Gonzalez Diaz, G | 1 |
| Feldstein, AC | 1 |
| Elmer, PJ | 1 |
| Nichols, GA | 1 |
| Herson, M | 1 |
| Couëtil, LL | 1 |
| Chilcoat, CD | 1 |
| DeNicola, DB | 1 |
| Clark, SP | 1 |
| Glickman, NW | 1 |
| Glickman, LT | 1 |
| Cai, M | 1 |
| Chen, H | 1 |
| Wang, XD | 1 |
| Zhang, HY | 1 |
| Botha, P | 1 |
| Steyn, D | 1 |
| Richter, DC | 1 |
| Bolliger, CT | 1 |
| Vondracek, SF | 1 |
| Hemstreet, BA | 1 |
| Carranza González, R | 1 |
| Tena Gómez, D | 1 |
| Prieto Gómez, E | 1 |
| Barberá Farré, JR | 1 |
| Fernández Cenjor, J | 1 |
| Valeyre, D | 1 |
| Lebargy, F | 1 |
| McGeoch, GR | 1 |
| Willsman, KJ | 1 |
| Dowson, CA | 1 |
| Town, GI | 1 |
| Frampton, CM | 1 |
| McCartin, FJ | 1 |
| de Wolf, MM | 1 |
| van der Krans, A | 1 |
| Frijns, CJ | 1 |
| Motegi, T | 1 |
| Yamada, K | 1 |
| Kida, K | 1 |
| Danley, SG | 1 |
| Regiane Resqueti, V | 1 |
| Gorostiza, A | 1 |
| Gáldiz, JB | 1 |
| López de Santa María, E | 1 |
| Casan Clarà, P | 1 |
| Güell Rous, R | 1 |
| Ferguson, AD | 1 |
| Manteca, A | 1 |
| Pelaez, AI | 1 |
| del Mar Garcia-Suarez, M | 1 |
| Hidalgo, E | 1 |
| del Busto, B | 1 |
| Mendez, FJ | 1 |
| Christ-Crain, M | 1 |
| Schild, U | 1 |
| Süess, E | 1 |
| Facompre, M | 1 |
| Baty, F | 1 |
| Nusbaumer, C | 1 |
| Brutsche, M | 1 |
| Perren, A | 1 |
| Cerutti, B | 1 |
| Lepori, M | 1 |
| Senn, V | 1 |
| Capelli, B | 1 |
| Duchini, F | 1 |
| Domenighetti, G | 1 |
| Anfinson, TJ | 1 |
| Channappa, C | 1 |
| Vo, HT | 1 |
| Khurana, R | 1 |
| Torzillo, PJ | 1 |
| Horsley, M | 1 |
| Mahoney, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD - a Randomized, Double-blind, Non-inferiority Study (The RECUT-Trial)"[NCT02386735] | 470 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting | |||
| Clinical Implementation and Outcomes Evaluation of Blood-Based Biomarkers for COPD Management: COPD Prednisone Sub-Study[NCT02534402] | Phase 4 | 40 participants (Actual) | Interventional | 2015-08-31 | Active, not recruiting | ||
| Clinical Implementation and Outcomes Evaluation of Blood-Based Biomarkers for Chronic Obstructive Pulmonary Disease Management[NCT02050022] | 522 participants (Actual) | Observational | 2013-04-30 | Active, not recruiting | |||
| Personalized Variable Versus Fixed Dose Corticosteroids Therapy in Hospitalized Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease[NCT02147015] | 248 participants (Actual) | Interventional | 2014-06-30 | Completed | |||
| The Value of Antibiotic Treatment of Exacerbations of Hospitalised COPD Patients[NCT00170222] | Phase 4 | 258 participants (Anticipated) | Interventional | 2002-07-31 | Completed | ||
| CRP-guided Antibiotic Treatment in Patients Hospitalized With Acute Exacerbations of COPD Patients. A Randomized Controlled Intervention Trial.[NCT01232140] | 220 participants (Anticipated) | Interventional | 2011-07-31 | Recruiting | |||
| A Prospective Baseline Assessment of the Risk of Osteoporosis in Patients With Chronic Obstructive Lung Disease and Outcomes After 2 Years; a Pilot Study[NCT01161680] | 30 participants (Actual) | Observational | 2010-07-31 | Completed | |||
| Impact of Telemedicine in the Rate of Readmission for COPD and Cost-effectiveness Analysis (e- Pneumo ) : Project CRONEX 3.0[NCT03505138] | 120 participants (Actual) | Interventional | 2018-05-01 | Completed | |||
| Adaptive Computerized COPD Exacerbation Self-management Support (ACCESS): A Randomized Controlled Trial[NCT02553096] | 87 participants (Actual) | Interventional | 2015-06-30 | Active, not recruiting | |||
| CSP #560 - Bronchitis and Emphysema Advice and Training to Reduce Hospitalization (BREATH)[NCT00395083] | Phase 2 | 426 participants (Actual) | Interventional | 2006-07-31 | Terminated (stopped due to The DMC detected an imbalance in safety outcomes between the two groups.) | ||
| Breathlessness Perception in COPD: Relationship With Exacerbation Frequency[NCT02113839] | 34 participants (Actual) | Interventional | 2014-04-30 | Completed | |||
| TNF-alpha Antagonists for Acute Exacerbations of COPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial[NCT00789997] | Phase 2/Phase 3 | 81 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| Effects of Fluticasone On Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease[NCT00175565] | Phase 4 | 50 participants | Interventional | 2002-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00395083)
Timeframe: From randomization until date of first hospitalization for COPD, assessed up to 26 months
| Intervention | years (Median) |
|---|---|
| Usual Care | 0.45 |
| Comprehensive Care Management Program | 0.46 |
(NCT00395083)
Timeframe: From randomization until death, assessed up to 26 months
| Intervention | years (Median) |
|---|---|
| Usual Care | 0.51 |
| Comprehensive Care Management Program | 0.49 |
(NCT00395083)
Timeframe: 26 months
| Intervention | participants (Number) | |
|---|---|---|
| All-Cause Death | Alive | |
| Comprehensive Care Management Program | 28 | 181 |
| Usual Care | 10 | 207 |
(NCT00395083)
Timeframe: 26 months
| Intervention | participants (Number) | |
|---|---|---|
| Subjects with COPD Hospitalization | Subjects without COPD Hospitalization | |
| Comprehensive Care Management Program | 36 | 173 |
| Usual Care | 34 | 183 |
"FEV1 was obtained using calibrated spirometers at approximately the same time of day at all visits throughout the study. The highest acceptable FEV1 and the highest FVC measurement each obtained on any of three blows (even if not from the same curve) meeting the American Thoracic Society criteria constituted the data for that test set.~Not all participants had Day 14 FEV1 measures collected" (NCT00789997)
Timeframe: Day 0 to Day 14
| Intervention | percentage of change in FEV1 (Mean) |
|---|---|
| Etanercept | 15.2 |
| Prednisone | 20.1 |
In the etanercept group 16/40 (40%) failed treatment compared with 12/38 (32%) in the prednisone group. (NCT00789997)
Timeframe: Day 0 to Day 90
| Intervention | participants (Number) |
|---|---|
| Etanercept | 16 |
| Prednisone | 12 |
10 reviews available for prednisone and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes | 2021 |
COPD exacerbations: 5 days of corticosteroid therapy.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Disease Progression; Dru | 2014 |
Severity of presentation is associated with time to recovery in spinal epidural lipomatosis.
Topics: Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Epidural Space; Female; Humans; Lipomatosis; Mi | 2015 |
Treating and preventing acute exacerbations of COPD.
Topics: Acidosis, Respiratory; Acute Disease; Administration, Inhalation; Albuterol; Anti-Bacterial Agents; | 2016 |
[Long-term trials assessing pharmacological treatments in COPD: lessons and limitations].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Androstadienes; Broncho | 2010 |
Clinical inquiries. Do systemic corticosteroids lessen symptoms in acute exacerbations of COPD?
Topics: Administration, Oral; Adrenal Cortex Hormones; Evidence-Based Medicine; Glucocorticoids; Humans; Pre | 2003 |
The role of systemic corticosteroids in acute exacerbation of chronic obstructive pulmonary disease.
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Drug Administration Schedule; Humans; | 2002 |
Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease?
Topics: Acute Disease; Clinical Trials as Topic; Drug Administration Schedule; Glucocorticoids; Humans; Pred | 2006 |
Steroid allergy? A case report and review of the literature.
Topics: Asthma; Drug Hypersensitivity; Glucocorticoids; Humans; Prednisone; Pulmonary Disease, Chronic Obstr | 2007 |
Drug dependence involving prednisone: two cases and a review of the literature.
Topics: Adult; Female; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; | 2008 |
23 trials available for prednisone and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
Topics: Administration, Oral; Adrenal Cortex Hormones; Ambulatory Care; Disease Progression; Double-Blind Me | 2019 |
Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Disease Progression; Dyspnea; Female; Glucocorticoids; | 2017 |
Dapagliflozin for prednisone-induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease.
Topics: Aged; Benzhydryl Compounds; Combined Modality Therapy; Diabetes Mellitus, Type 2; Double-Blind Metho | 2018 |
Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Gene Expression | 2019 |
Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Gene Expression | 2019 |
Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Gene Expression | 2019 |
Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Gene Expression | 2019 |
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Topics: Acute Disease; Aged; Disease Progression; Double-Blind Method; Female; Glucocorticoids; Humans; Male | 2013 |
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Topics: Acute Disease; Aged; Disease Progression; Double-Blind Method; Female; Glucocorticoids; Humans; Male | 2013 |
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Topics: Acute Disease; Aged; Disease Progression; Double-Blind Method; Female; Glucocorticoids; Humans; Male | 2013 |
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Topics: Acute Disease; Aged; Disease Progression; Double-Blind Method; Female; Glucocorticoids; Humans; Male | 2013 |
Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Disease Progression; Female; Humans; Hyperglyc | 2014 |
[5 days of systemic steroids in COPD exacerbation are adequate].
Topics: Administration, Oral; Adult; Disease Progression; Drug Administration Schedule; Drug Therapy, Combin | 2013 |
Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial.
Topics: Adrenal Cortex Function Tests; Adrenal Cortex Hormones; Adrenal Glands; Adrenal Insufficiency; Adren | 2015 |
Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study.
Topics: Administration, Inhalation; Administration, Intravenous; Aged; Aged, 80 and over; Albuterol; Broncho | 2015 |
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Bronchodilator Agents; Budesonide; Doubl | 2017 |
Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cr | 2009 |
Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial In | 2010 |
Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial In | 2010 |
Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial In | 2010 |
Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial In | 2010 |
Effects of written action plan adherence on COPD exacerbation recovery.
Topics: Aged; Anti-Bacterial Agents; Canada; Delivery of Health Care; Drug Administration Schedule; Drug Pre | 2011 |
Effects of written action plan adherence on COPD exacerbation recovery.
Topics: Aged; Anti-Bacterial Agents; Canada; Delivery of Health Care; Drug Administration Schedule; Drug Pre | 2011 |
Effects of written action plan adherence on COPD exacerbation recovery.
Topics: Aged; Anti-Bacterial Agents; Canada; Delivery of Health Care; Drug Administration Schedule; Drug Pre | 2011 |
Effects of written action plan adherence on COPD exacerbation recovery.
Topics: Aged; Anti-Bacterial Agents; Canada; Delivery of Health Care; Drug Administration Schedule; Drug Pre | 2011 |
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Case Management; Cause of Death; Depression; | 2012 |
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Case Management; Cause of Death; Depression; | 2012 |
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Case Management; Cause of Death; Depression; | 2012 |
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Case Management; Cause of Death; Depression; | 2012 |
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Double-Blind Method; Etanercept; | 2013 |
Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.
Topics: Acute Disease; Administration, Oral; Aged; Ambulatory Care; Double-Blind Method; Emergency Treatment | 2003 |
Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Aged; Aged, 80 and over; Androstadienes; Anti-Infl | 2004 |
A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Delayed-Acti | 2005 |
Randomized, controlled study of inhaled fluticasone propionate, oral administration of prednisone, and environmental management of horses with recurrent airway obstruction.
Topics: Analysis of Variance; Androstadienes; Animals; Bronchoalveolar Lavage; Environment; Fluticasone; Hor | 2005 |
Time to spirometric and exercise response in 4-week oral corticosteroid trial for stable COPD patients.
Topics: Administration, Oral; Exercise Test; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Male | 2005 |
Self-management plans in the primary care of patients with chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anxiety; Depression; Female; Glucocorticoids; Humans | 2006 |
[Benefits of a home-based pulmonary rehabilitation program for patients with severe chronic obstructive pulmonary disease].
Topics: Aged; Albuterol; Anthropometry; Anti-Inflammatory Agents; Bronchodilator Agents; Female; Home Care S | 2007 |
Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; C-Reactive Protein; Calcitonin; Calcitonin Ge | 2008 |
56 other studies available for prednisone and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
A multifaceted stewardship intervention helps curb steroid overprescribing in hospitalized patients with acute exacerbations of COPD.
Topics: Adrenal Cortex Hormones; Adult; Humans; Inappropriate Prescribing; Prednisone; Pulmonary Disease, Ch | 2022 |
[Dutch guideline to prevent perioperative pulmonal complications: how is the adherence?]
Topics: Adrenal Cortex Hormones; Asthma; Guideline Adherence; Humans; Prednisolone; Prednisone; Pulmonary Di | 2022 |
Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients.
Topics: Aged; Asthma; Humans; Nutrition Assessment; Prednisone; Prognosis; Pulmonary Disease, Chronic Obstru | 2023 |
Provider perceptions on steroid dosing in AECOPD: Laying the groundwork for steroid stewardship.
Topics: Adrenal Cortex Hormones; Emergency Service, Hospital; Humans; Perception; Prednisone; Pulmonary Dise | 2020 |
Corticosteroid Exposure in the Treatment of Severe COPD Exacerbations.
Topics: Adrenal Cortex Hormones; Disease Progression; Glucocorticoids; Humans; Prednisone; Pulmonary Disease | 2022 |
When to consider Pneumocystis jirovecii prophylaxis in HIV-negative patients.
Topics: Aged; Anti-Bacterial Agents; Bendamustine Hydrochloride; HIV Seronegativity; Humans; Immunocompromis | 2021 |
Hidden in Plain Sight: An Elusive Cause of Cardiogenic Shock.
Topics: Electrocardiography; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prednisone; Pulmonary Di | 2021 |
A 69-Year-Old Woman With Ulcerative Colitis and Pulmonary Nodules.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Colitis, Ulcerative; Cryptogenic Organizing Pneumonia; Diagn | 2021 |
Is it safe to start steroids at home for a COPD exacerbation after virtual assessment in the COVID-19 era?
Topics: COVID-19; Duration of Therapy; Humans; Male; Middle Aged; Prednisone; Pulmonary Disease, Chronic Obs | 2021 |
Relationship of Steroid Dosing and Duration of Mechanical Ventilation in Adult Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Topics: Acute Disease; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glucoco | 2018 |
The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study.
Topics: Aged; Disease Progression; Electronic Health Records; Female; Glucocorticoids; Hospitalization; Huma | 2018 |
Systemic Corticosteroid and Antibiotic Use in Hospitalized Patients With Chronic Obstructive Pulmonary Disease Exacerbation.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Disease Progression; Female; Glucocorticoids; Hospitali | 2019 |
Disseminated nocardiosis with cerebral and subcutaneous lesions on low-dose prednisone.
Topics: Aged; Anti-Inflammatory Agents; Brain; Humans; Immunocompromised Host; Male; Nocardia Infections; Op | 2019 |
Chylothorax due to Venous Thrombosis in a Double-Lung Transplant Patient.
Topics: Acute Kidney Injury; Chylothorax; Combined Modality Therapy; Cytomegalovirus Infections; Diet, Fat-R | 2019 |
Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lu | 2019 |
Obstructive inflammatory tracheal pseudomembrane.
Topics: Aged; Airway Obstruction; Anti-Inflammatory Agents; Bronchi; Combined Modality Therapy; Cough; Exuda | 2013 |
Detection of COPD Exacerbations and compliance with patient-reported daily symptom diaries using a smart phone-based information system [corrected].
Topics: Adult; Aged; Anti-Bacterial Agents; Cell Phone; Disease Progression; Female; Glucocorticoids; Humans | 2013 |
Steroids for treatment of COPD exacerbations: less is clearly more.
Topics: Female; Glucocorticoids; Humans; Male; Prednisone; Pulmonary Disease, Chronic Obstructive | 2013 |
[Achilles heel of COPD].
Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aza Compounds; Diagnosis, Di | 2013 |
[Not Available].
Topics: Female; Glucocorticoids; Humans; Male; Prednisone; Pulmonary Disease, Chronic Obstructive | 2013 |
5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation.
Topics: Female; Glucocorticoids; Humans; Male; Prednisone; Pulmonary Disease, Chronic Obstructive | 2013 |
A 5-day course of systemic corticosteroids is adequate to treat acute exacerbations of chronic obstructive pulmonary disease.
Topics: Female; Glucocorticoids; Humans; Male; Prednisone; Pulmonary Disease, Chronic Obstructive | 2014 |
[Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of 3 cases].
Topics: Aged; Aged, 80 and over; Antibodies, Fungal; Aspergillosis, Allergic Bronchopulmonary; Humans; Immun | 2013 |
Steroids for acute COPD--but for how long?
Topics: Female; Glucocorticoids; Humans; Male; Prednisone; Pulmonary Disease, Chronic Obstructive | 2014 |
A clinical prediction tool for prognosis in patients with cystic fibrosis, short-term glucocorticoid therapy for chronic obstructive pulmonary disease, and laryngeal ultrasound for prediction of postextubation laryngeal edema.
Topics: Cystic Fibrosis; Decision Support Techniques; Female; Glucocorticoids; Humans; Lung; Male; Prednison | 2014 |
Systemic steroids in severe forms of COPD exacerbations: a question of balance?
Topics: Anti-Inflammatory Agents; Female; Humans; Male; Prednisone; Pulmonary Disease, Chronic Obstructive | 2014 |
Improving adherence for management of acute exacerbation of chronic obstructive pulmonary disease.
Topics: Continuity of Patient Care; Drug Utilization; Electronic Health Records; Female; Glucocorticoids; Gu | 2014 |
INTERACTIVE MEDICAL CASE. A Woman with Dyspnea and Altered Mental Status.
Topics: Acyclovir; Diagnosis, Differential; Dyspnea; Electrocardiography; Encephalitis, Varicella Zoster; Fe | 2016 |
Antibiotics in acute exacerbations of chronic obstructive pulmonary disease.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis, Chr | 2009 |
Central airways obstruction due to Aspergillus fumigatus after lung transplantation.
Topics: Airway Obstruction; Antifungal Agents; Aspergillus fumigatus; Bronchoscopy; Diagnosis, Differential; | 2009 |
Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease - a population-based database study.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Male; Mass Screeni | 2010 |
Impact of cytomegalovirus infection in lung transplant patients under universal prophylaxis: single-center experience in Brazil.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Basiliximab; Brazil; Bronchiectasis; Cohort Studies; Cy | 2010 |
Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol.
Topics: Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Glucocort | 2011 |
Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin.
Topics: Aged; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Follow-Up Studies; Humans; Hyp | 2012 |
Demographic, physiologic and radiographic characteristics of COPD patients taking chronic systemic corticosteroids.
Topics: Administration, Oral; Adrenergic beta-Agonists; Asthma; Bronchodilator Agents; Female; Forced Expira | 2012 |
Summaries for patients. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Case Management; Cause of Death; Female; Foll | 2012 |
Biochemistry: A radical treatment.
Topics: Animals; Antioxidants; Clinical Trials as Topic; Disease Models, Animal; Free Radicals; Humans; Isot | 2012 |
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Topics: Acute Disease; Administration, Oral; Glucocorticoids; Humans; Prednisone; Pulmonary Disease, Chronic | 2003 |
Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
Topics: Aged; Animals; Antiprotozoal Agents; Diagnosis, Differential; Facial Dermatoses; Humans; Immunocompr | 2003 |
Prednisone for chronic obstructive pulmonary disease.
Topics: Administration, Oral; Data Interpretation, Statistical; Glucocorticoids; Humans; Prednisone; Pulmona | 2003 |
Prednisone for chronic obstructive pulmonary disease.
Topics: Dyspnea; Glucocorticoids; Humans; Prednisone; Pulmonary Disease, Chronic Obstructive; Secondary Prev | 2003 |
Prednisone for chronic obstructive pulmonary disease.
Topics: Bronchodilator Agents; Forced Expiratory Volume; Glucocorticoids; Humans; Prednisone; Pulmonary Dise | 2003 |
Prednisone for chronic obstructive pulmonary disease.
Topics: Administration, Oral; Adrenal Gland Diseases; Aged; Bone Density; Glucocorticoids; Humans; Prednison | 2003 |
Oral prednisone prevents relapse in COPD exacerbations.
Topics: Administration, Oral; Aged; Ambulatory Care; Anti-Inflammatory Agents; Double-Blind Method; Dyspnea; | 2003 |
Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids.
Topics: Administration, Oral; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Interleuki | 2004 |
Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
Topics: Antiprotozoal Agents; Bone Marrow; Bone Marrow Diseases; Fatal Outcome; Glucocorticoids; HIV Seroneg | 2005 |
Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Asthma; Bone De | 2005 |
[Clinical observation of bushen naqi huoxue granules in treating patients with chronic obstructive lung disease].
Topics: Adult; Aged; Aminophylline; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Forced Expirat | 2005 |
[Pneumonia by Corynebacterium pseudodiphteriticum: an infection to consider].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Corynebacte | 2006 |
[Sarcoidosis and granulomatous disease: observation].
Topics: Anti-Inflammatory Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Mid | 2006 |
[Spontaneous bilateral rupture of the Achilles tendon in an elderly woman undergoing prednisone pulse therapy with a history of polymyalgia rheumatica].
Topics: Achilles Tendon; Aged, 80 and over; Female; Glucocorticoids; Humans; Polymyalgia Rheumatica; Prednis | 2006 |
[Cost analysis for inpatient therapy for patients with acute exacerbations of chronic obstructive pulmonary disease].
Topics: Activities of Daily Living; Adult; Aged; Costs and Cost Analysis; Female; Health Care Costs; Hospita | 2006 |
Rhinocerebral mucormycosis acquired after a short course of prednisone therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Comorbidity; Diabetes Mellitus; Disease Pro | 2007 |
A rare case of lung coinfection by Streptomyces cinereoruber and Haemophilus influenzae in a patient with severe chronic obstructive pulmonary disease: characterization at species level using molecular techniques.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Typing Techniques; DNA, Bacterial; | 2008 |
Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aged; Aged, 80 and over; Diagnostic Techniques, | 2008 |
Spontaneous bilateral rupture of the Achilles tendon in a patient with chronic obstructive pulmonary disease.
Topics: Achilles Tendon; Aged; Glucocorticoids; Humans; Male; Prednisone; Pulmonary Disease, Chronic Obstruc | 2002 |